Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro.
Sudden hearing loss as the initial symptom in Japanese patients with multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Transcranial sonography of subcortical structures in patients with multiple sclerosis.
Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
Study of communication in relapsing-remitting multiple sclerosis (RRMS): Disorders of the pragmatics of language, theory of mind and facial emotion processing.
Interferon beta-1b-induced postmenopausal bleeding in a patient with multiple sclerosis.
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling.
MicroRNAs associated with the pathogenesis of multiple sclerosis.
Quantitative MRI in hypomyelinating disorders: Correlation with motor handicap.
Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in Children: Experience in a Tertiary Center, Upper Egypt.
Poster 487 Chronic Inflammatory Demyelinating Polyneuropathy or Something Else?: A Case Report.
Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis.
Inflammatory demyelinating neuropathy heralding accelerated Chediak-Higashi syndrome.
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
A genetic basis for multiple sclerosis severity: Red herring or real?
Laparoscopic Radical Cystectomy and Ileal Neobladder for Muscle Invasive Bladder Cancer in Combination with One Stage Prophylactic Laparoscopic Sacrospinal Fixation to Avoid Future Pelvic Organ Prolapse.
Transcriptional Fingerprint of Hypomyelination in Zfp191null and Shiverer (Mbpshi) Mice.
Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Pages
« first
‹ previous
…
807
808
809
810
811
812
813
814
815
…
next ›
last »